Increased Risk of Atrial Fibrillation in the Early Period after Herpes Zoster Infection: a Nationwide Populationbased Case-control Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cha, Myung-Jin | - |
dc.contributor.author | Seo, Hyun-Min | - |
dc.contributor.author | Choi, Eue-Keun | - |
dc.contributor.author | Lee, Ji Hyun | - |
dc.contributor.author | Han, Kyungdo | - |
dc.contributor.author | Lee, So-Ryoung | - |
dc.contributor.author | Lim, Woo-Hyun | - |
dc.contributor.author | Park, Young Min | - |
dc.contributor.author | Oh, Seil | - |
dc.date.accessioned | 2021-08-11T12:23:53Z | - |
dc.date.available | 2021-08-11T12:23:53Z | - |
dc.date.issued | 2018-05-28 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5965 | - |
dc.description.abstract | Background: Herpes zoster (HZ) is a chronic inflammatory disease that could result in autonomic dysfunction, often leading to atrial fibrillation (AF). Methods: From the Korean National Health Insurance Service database of 738,559 subjects, patients newly diagnosed with HZ (n = 30,685) between 2004 and 2011, with no history of HZ or AF were identified. For the non-HZ control group, 122,740 age- and sex-matched subjects were selected. AF development in the first two-years following HZ diagnosis, and during the overall follow-up period were compared among severe (requiring hospitalization, n = 2,213), mild (n = 28,472), and non-HZ (n = 122,740) groups. Results: There were 2,204 (1.4%) patients diagnosed with AF during follow-up, and 825 (0.5%) were diagnosed within the first two years after HZ. The severe HZ group showed higher rates of AF development (6.4 per 1,000 patient-years [PTPY]) compared to mild-HZ group (2.9 PTPY) and non-HZ group (2.7 PTPY). The risk of developing AF was higher in the first two-years after HZ diagnosis in the severe HZ group (10.6 PTPY vs. 2.7 PTPY in mild-HZ group and 2.6 PTPY in non-HZ group). Conclusion: Severe HZ that requires hospitalization shows an increased risk of incident AF, and the risk is higher in the first two-years following HZ diagnosis. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한의학회 | - |
dc.title | Increased Risk of Atrial Fibrillation in the Early Period after Herpes Zoster Infection: a Nationwide Populationbased Case-control Study | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3346/jkms.2018.33.e160 | - |
dc.identifier.scopusid | 2-s2.0-85047509061 | - |
dc.identifier.wosid | 000433234500005 | - |
dc.identifier.bibliographicCitation | Journal of Korean Medical Science, v.33, no.22 | - |
dc.citation.title | Journal of Korean Medical Science | - |
dc.citation.volume | 33 | - |
dc.citation.number | 22 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | AUTONOMIC NERVOUS-SYSTEM | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | VALIDITY | - |
dc.subject.keywordPlus | VIRUS | - |
dc.subject.keywordAuthor | Atrial Fibrillation | - |
dc.subject.keywordAuthor | Herpes Zoster | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Autonomic Dysfunction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.